Product
BOTOX®
3 clinical trials
5 indications
Indication
Frown LinesIndication
urinary incontinenceIndication
BladderIndication
OveractiveIndication
Glabellar LinesClinical trial
Double-blind, Randomized, Parallel Design, Active-controlled Phase 1 Clinical Trial to Evaluate the Efficacy and Safety of DWP712 and Botox® in Adult Patients in Need of Moderate to Severe Glabellar LinesStatus: Completed, Estimated PCD: 2024-02-26
Clinical trial
BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in Patients 12 to 17 Years of AgeStatus: Terminated, Estimated PCD: 2022-02-10
Clinical trial
A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar LinesStatus: Recruiting, Estimated PCD: 2024-10-25